Stroke Research Studies
The Swedish Stroke Program participates in clinical research studies in order to make the most leading-edge therapies available to our patients.
Title of Study: Clotbuster-ER
Short Description: Ultrasound and Systemic Tissue Plasminogen Activator of Emergent Revascularization in Acute Ischemic Stroke
Principal Investigator: William Likosky, MD
Enrollment Status: Closed
Title of Study: Aldagen
Short Description: Delivery of ALD-401 derived from Autologous Bone Marrow by intracarotid infusion in subjects who have had unilateral, predominately cortical, ischemic strokes in the middle carotid artery (MCA).
Principal Investigator: William Likosky, MD
Enrollment Status: Closed (patients in follow-up)
Title of Study: MISTIE III
Short Description: Combination of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage.
Principal Investigator: David Newell, MD
Enrollment Status: Start-up
Title of Study: Northstar Everest
Short Description: Cortical Stimulation in the treatment of Upper Extremity Hemiparesis
Principal Investigator: Ryder Gwinn, MD
Enrollment Status: Closed
Title of Study: AVAIL
Short Description: Stroke quality improvement registry
Principal Investigator: William Likosky, MD
Enrollment Status: Closed
Title of Study: DEFUSE 2
Short Description: Diffusion weighted imaging evaluation for understanding stroke evolution.
Principal Investigator: Bart Keogh, MD
Enrollment Status: Closed
Title of Study: DIAS-4
Short Description: Study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke.
Principal Investigator: William Likosky, MD
Enrollment Status: Closed
Title of Study: CoAxia
Short Description: Safety and efficacy study of Neuroflo Technology in Ischemic stroke
Principal Investigator: William Likosky, MD
Enrollment Status: Closed
Title of Study: Clear III
Short Description: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage
Principal Investigator: David Newell, MD
Enrollment Status: Closed
Title of Study: Sleuth
Short Description: Safety and Efficacy of Lysis ultrasound in the treatment of Intracerebral and intraventricular hemorrhage.
Principal Investigator: David Newell, MD
Enrollment Status: Closed
Title of Study: COSS
Short Description: Carotid Occlusion Surgery Study
Principal Investigator: David Newell, MD
Enrollment Status: Closed
Title of Study: Aruba
Short Description: Medical management vs. interventional therapy of unruptured brain AVMs.
Principal Investigator: David Newell, MD
Enrollment Status: Closed
Title of Study: Tucson Imarx
Short Description: Ascending single doses of MRX-801 with continuous ultrasound administration in Subjects with Acute Ischemic Stroke Receiving Treatment with IV tPA.
Principal Investigator: William Likosky, MD
Enrollment Status: Closed
Title of Study: Penumbra
Short Description: To assess the safety and effectiveness of the Separator 3D as a component of the Penumbra System in the revascularization of large vessel occlusion in acute ischemic stroke.
Principal Investigator: Yince Loh, MD
Enrollment Status: Closed
Title of Study: PRISMS
Short Description: A Phase IIIB, Double-blind, Multicenter Study to evaluate the efficacy and safety of Alteplase in patients with mild stroke: Rapidly improving Systems minor neurologic deficits (PRISMS)
Principal Investigator: Aaron Stayman, MD
Enrollment Status: Start-Up
Title of Study: SOCRATES
Short Description: A Randomized, Double-blind, Multinational Study to prevent major Vascular Events with Ticagrelor Compared to Aspiring (ASA) in Patients with Acute Ischemic Stroke or TIA.
Principal Investigator: Ravi Menon, MD
Enrollment Status: Start-Up
Learn more about other Swedish research studies.
Swedish is participating in a new research study to test a new medication for patients in the critical first few hours after having a stroke. This study is testing the effectiveness of desmoteplase – a substance found in vampire bats. Read more on page A4 of Physicians Practice.
News
How Bats Are Helping Treat Stroke Patients